Clinical trial
Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral…
NCT00343148 · Sarepta Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00343148 |
|---|---|
| Title | Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid |
| Official title | Pharmacokinetic Study of AVI-4126 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration |
| Lead sponsor | Sarepta Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | AVI-4126 Injection (RESTEN-NG®) |
| Enrollment | 6 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2009 |
| First posted | Jun 22, 2006 |
| Last update posted | Jul 8, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: